Affymetrix Hosts Two Cancer Genomics Workshops at 2007 NCRI Conference

Affymetrix Inc. (Nasdaq:AFFX) announced today that it is hosting two workshops at the third NCRI Cancer Conference in Birmingham, U.K. The ability to combine information from gene expression profiling, copy number alterations, loss of heterozygosity, alternative splicing and gene regulation is pivotal to understanding the molecular basis of cancer.

Source: Affymetrix, Inc.